William Winters
Psychiatry · South Daytona, FLNPI 1124297296
Payments from drug & device makers
Across 123 payments — averaging $324.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avadel CNS Pharmaceuticals, LLC$37K
- AbbVie$714
- Harmony Biosciences LLC$456
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$282
- Idorsia Pharmaceuticals US Inc$225
- Sunovion Pharmaceuticals Inc.$216
- plus $683 from 15 others
What the payments were for
- Speaking & faculty fees$30,60077%
- Travel & lodging$6,20116%
- Food & beverage$3,0438%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,852 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 47 | $70,164 |
| Vilazodone Hcl | 34 | $2,889 |
| Trazodone Hcl | 132 | $2,426 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 51 | $1,929 |
| Alprazolam ErAlprazolam | 48 | $1,883 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 22 | $1,223 |
| Clorazepate Dipotassium | 13 | $1,219 |
| Bupropion XlBupropion Hcl | 61 | $1,194 |
| Methylphenidate ErMethylphenidate Hcl | 18 | $877 |
| Aripiprazole | 46 | $668 |
| Lamotrigine | 41 | $638 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 38 | $556 |
| Propranolol Hcl | 16 | $490 |
| Temazepam | 36 | $486 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 19 | $456 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $204 | $70,16447 claims |
| Almatica Pharma LLCSertraline Hcl | $32 | $25840 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in South Daytona
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
- Olga LapeyraLauderhill$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.